Eli Lilly Expands LillyDirect Platform to Improve Access to Alzheimer's Disease Care in the U.S.

Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent in-person and telehealth opti...

March 28, 2025 | Friday | News
Sanofi’s mRNA Chlamydia Vaccine Candidate Receives Fast Track Designation from FDA

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. ...

March 28, 2025 | Friday | News
Merck and Hengrui Pharma Forge $1.97 Billion Global Partnership to Advance Novel Lp(a) Inhibitor for Cardiovascular Disease

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”), a ...

March 26, 2025 | Wednesday | News
GSK Wins FDA Approval for Blujepa, First New Oral Antibiotic for UTIs in Nearly 30 Years

GSK plc announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 kg...

March 26, 2025 | Wednesday | News
B. Braun Launches 3 g Cefazolin in DUPLEX® for Surgical Infection Prevention

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced the launch of its new Cefazolin 3 g, the latest cefazol...

March 25, 2025 | Tuesday | News
Sanofi Accelerates Flu Vaccine Production for 2025-26 Season, Aligning with FDA-Selected Strains

Sanofi announced the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...

March 17, 2025 | Monday | News
Autonomix Advances Sensing and RF Ablation System Toward U.S. Clinical Trials for Pancreatic Cancer Pain

Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF&rdq...

March 14, 2025 | Friday | News
Doer Bio Completes Phase 2 Enrollment for DR10624 Tri-Agonist in Severe Hypertriglyceridemia

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...

March 10, 2025 | Monday | News
Neurocrine Biosciences Begins Phase 1 Trial for NBI-1140675 in Neurological Disorders

Neurocrine Biosciences, Inc. announced the initiation of a Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynami...

March 06, 2025 | Thursday | News
GHIT Fund Marks Milestone with First Administration of Arpraziquantel to Preschool Children in Uganda

The Global Health Innovative Technology (GHIT) Fund is announcing a significant milestone: the first administration of arpraziquantel to preschool-aged chi...

March 05, 2025 | Wednesday | News
Myriad Genetics Partners with Gabbi to Enhance Breast Cancer Risk Assessment and Specialist Care

Myriad Genetics, Inc., a leader in molecular diagnostics testing and precision medicine, announced a collaboration with Gabbi, a telehealth solution f...

February 28, 2025 | Friday | News
Roche Receives FDA Approval for Evrysdi® Tablet for Spinal Muscular Atrophy

 Roche  announced  that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an Evrysdi® (risdiplam...

February 13, 2025 | Thursday | News
NeuFit Revolutionizes Neurological Rehabilitation with Innovative NEUBIE Device

 NeuFit is revolutionizing neurological rehabilitation with its innovative approach that integrates advanced diagnostics and therapeutic technolo...

February 06, 2025 | Thursday | News
Zoetis Updates U.S. Label for Librela® (bedinvetmab) Following Post-Approval Experience

Zoetis Inc. announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission of a supplement to the U.S...

February 05, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close